Xilio Therapeutics, Inc. (XLO)
USD 0.87
(-6.56%)
USD 0.87
(-6.56%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | - | - | - | - | - |
| Cost of Revenue | 1.9 Million | 1.84 Million | 1.49 Million | 1.06 Million | 240 Thousand |
| Gross Profit | -1.9 Million | -1.84 Million | -1.49 Million | -1.06 Million | -240 Thousand |
| Operating Expenses | 79.13 Million | 89.14 Million | 75.04 Million | 54.56 Million | 19.02 Million |
| Selling, General and Administrative Expenses | 26.99 Million | 29.94 Million | 23.85 Million | 10.65 Million | 4.77 Million |
| Research and Development Expenses | 52.13 Million | 59.2 Million | 51.18 Million | 43.91 Million | 14.25 Million |
| Other Expenses | - | 927 Thousand | -756 Thousand | -656 Thousand | 1.71 Million |
| Cost and Expenses | 79.13 Million | 89.14 Million | 75.04 Million | 54.56 Million | 19.02 Million |
| Operating Income | -79.13 Million | -89.14 Million | -75.04 Million | -54.56 Million | -19.02 Million |
| Interest Expense | - | - | 600 Thousand | 600 Thousand | - |
| Income Tax Expense | - | -927 Thousand | -1.49 Million | 858.7 Thousand | 68.14 Thousand |
| Earnings before Tax | -76.4 Million | -88.22 Million | -75.8 Million | -55.21 Million | -17.31 Million |
| Net Income | -76.4 Million | -87.29 Million | -74.3 Million | -55.21 Million | -17.31 Million |
| Earnings Per Share Basic | -2.78 | -3.19 | -2.72 | -2.01 | -0.00 |
| Earnings Per Share Diluted | -2.78 | -3.19 | -2.72 | -2.01 | -0.00 |
| Weighted Average Shares Outstanding | 27.49 Million | 27.39 Million | 27.35 Million | 27.46 Million | 27.46 Billion |
| Weighted Average Shares Outstanding (Diluted) | 27.49 Million | 27.39 Million | 27.35 Million | 27.46 Million | 27.46 Billion |
| Gross Margin | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - |
| Profit Margin | - | - | - | - | - |
| EBITDA | -73.8 Million | -85.57 Million | -73.7 Million | -53.49 Million | -17.07 Million |
| Earnings Before Tax Margin | - | - | - | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 2.35 Million | - | 2.9 Million | - | - | - |
| Cost of Revenue | 445 Thousand | 443 Thousand | 449 Thousand | 1.9 Million | 460 Thousand | 492 Thousand |
| Gross Profit | 1.91 Million | -443 Thousand | 2.45 Million | -1.9 Million | -460 Thousand | -492 Thousand |
| Operating Expenses | 16.58 Million | 16.09 Million | 17.68 Million | 77.23 Million | 17.36 Million | 20.11 Million |
| Selling, General and Administrative Expenses | 5.37 Million | 5.69 Million | 5.94 Million | - | 6.31 Million | 6.89 Million |
| Research and Development Expenses | 11.21 Million | 10.4 Million | 11.73 Million | - | 11.05 Million | 13.21 Million |
| Other Expenses | 779 Thousand | 284 Thousand | -2.25 Million | - | 613 Thousand | 761 Thousand |
| Cost and Expenses | 17.03 Million | 16.53 Million | 18.13 Million | 79.13 Million | 17.36 Million | 20.11 Million |
| Operating Income | -14.67 Million | -16.53 Million | -18.13 Million | -79.13 Million | -17.36 Million | -20.11 Million |
| Interest Expense | - | - | 100 Thousand | - | 200 Thousand | 200 Thousand |
| Income Tax Expense | - | 1.00 | 1.37 Million | - | 499.58 Thousand | 369.91 Thousand |
| Earnings before Tax | -13.92 Million | -17.2 Million | -17.65 Million | -76.4 Million | -16.74 Million | -19.35 Million |
| Net Income | -13.92 Million | -17.2 Million | -17.65 Million | -76.4 Million | -16.74 Million | -19.35 Million |
| Earnings Per Share Basic | -0.24 | -0.62 | -0.64 | - | -0.61 | -0.70 |
| Earnings Per Share Diluted | -0.24 | -0.62 | -0.64 | - | -0.61 | -0.70 |
| Weighted Average Shares Outstanding | 57.76 Million | 27.91 Million | 27.55 Million | 27.49 Million | 27.52 Million | 27.46 Million |
| Weighted Average Shares Outstanding (Diluted) | 57.76 Million | 27.91 Million | 27.55 Million | 27.49 Million | 27.52 Million | 27.46 Million |
| Gross Margin | 0.81 | - | 0.85 | - | - | - |
| EBIT Margin | -6.04 | - | -6.09 | - | - | - |
| Profit Margin | -5.91 | - | -6.08 | - | - | - |
| EBITDA | -14.22 Million | -16.09 Million | -17.68 Million | - | -16.9 Million | -19.62 Million |
| Earnings Before Tax Margin | -6.23 | - | -6.25 | - | - | - |
SAVA
600368
6093
EMMN
603797
RAMANEWS